Oprea I - Search Results

1

Progresses towards safe and efficient gene therapy vectors.

Chira S, Jackson CS, Oprea I, Ozturk F, Pepper MS, Diaconu I, Braicu C, Raduly LZ, Calin GA, Berindan-Neagoe I. Chira S, et al. Among authors: oprea i. Oncotarget. 2015 Oct 13;6(31):30675-703. doi: 10.18632/oncotarget.5169. Oncotarget. 2015. PMID: 26362400 Free PMC article. Review.

2

Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes.

Suleymanova N, Crudden C, Shibano T, Worrall C, Oprea I, Tica A, Calin GA, Girnita A, Girnita L. Suleymanova N, et al. Among authors: oprea i. Oncogene. 2017 Oct 12;36(41):5734-5744. doi: 10.1038/onc.2017.179. Epub 2017 Jun 5. Oncogene. 2017. PMID: 28581517 Free PMC article.

3

β-Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing's sarcoma.

Zheng H, Shen H, Oprea I, Worrall C, Stefanescu R, Girnita A, Girnita L. Zheng H, et al. Among authors: oprea i. Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20620-5. doi: 10.1073/pnas.1216348110. Epub 2012 Nov 27. Proc Natl Acad Sci U S A. 2012. PMID: 23188799 Free PMC article.

4

Nanotechnology approaches for gene transfer.

Lundin KE, Simonson OE, Moreno PM, Zaghloul EM, Oprea II, Svahn MG, Smith CI. Lundin KE, et al. Among authors: oprea ii. Genetica. 2009 Sep;137(1):47-56. doi: 10.1007/s10709-009-9372-0. Epub 2009 Jun 2. Genetica. 2009. PMID: 19488829 Review.

5

Non-viral nanovectors for gene delivery: factors that govern successful therapeutics.

Viola JR, El-Andaloussi S, Oprea II, Smith CI. Viola JR, et al. Among authors: oprea ii. Expert Opin Drug Deliv. 2010 Jun;7(6):721-35. doi: 10.1517/17425241003716810. Expert Opin Drug Deliv. 2010. PMID: 20367531 Review.

6

Fatty acid-spermine conjugates as DNA carriers for nonviral in vivo gene delivery.

Viola JR, Leijonmarck H, Simonson OE, Oprea II, Frithiof R, Purhonen P, Moreno PM, Lundin KE, Strömberg R, Smith CI. Viola JR, et al. Among authors: oprea ii. Gene Ther. 2009 Dec;16(12):1429-40. doi: 10.1038/gt.2009.108. Gene Ther. 2009. PMID: 19727137

7

Novel mechanisms of regulation of IGF-1R action: functional and therapeutic implications.

Worrall C, Nedelcu D, Serly J, Suleymanova N, Oprea I, Girnita A, Girnita L. Worrall C, et al. Among authors: oprea i. Pediatr Endocrinol Rev. 2013 Jul;10(4):473-84. Pediatr Endocrinol Rev. 2013. PMID: 23957198 Review.

8

Development of bis-locked nucleic acid (bisLNA) oligonucleotides for efficient invasion of supercoiled duplex DNA.

Moreno PM, Geny S, Pabon YV, Bergquist H, Zaghloul EM, Rocha CS, Oprea II, Bestas B, Andaloussi SE, Jørgensen PT, Pedersen EB, Lundin KE, Zain R, Wengel J, Smith CI. Moreno PM, et al. Among authors: oprea ii. Nucleic Acids Res. 2013 Mar 1;41(5):3257-73. doi: 10.1093/nar/gkt007. Epub 2013 Jan 23. Nucleic Acids Res. 2013. PMID: 23345620 Free PMC article.

9

Repeatable, Inducible Micro-RNA-Based Technology Tightly Controls Liver Transgene Expression.

Oprea II, Viola JR, Moreno PM, Simonson OE, Rodin S, Teller N, Tryggvason K, Lundin KE, Girnita L, Smith CI. Oprea II, et al. Mol Ther Nucleic Acids. 2014 Jul 1;3(7):e172. doi: 10.1038/mtna.2014.25. Mol Ther Nucleic Acids. 2014. PMID: 24983837 Free PMC article.

10

Temperature-assisted cyclic hybridization (TACH): an improved method for supercoiled DNA hybridization.

Oprea II, Simonson OE, Moreno PM, Viola JR, Lundin KE, Smith CI. Oprea II, et al. Mol Biotechnol. 2010 Jun;45(2):171-9. doi: 10.1007/s12033-010-9261-x. Mol Biotechnol. 2010. PMID: 20238183

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page